120 related articles for article (PubMed ID: 37973299)
21. Acute aquatic toxicity assessment of six anti-cancer drugs and one metabolite using biotest battery - Biological effects and stability under test conditions.
Białk-Bielińska A; Mulkiewicz E; Stokowski M; Stolte S; Stepnowski P
Chemosphere; 2017 Dec; 189():689-698. PubMed ID: 28968575
[TBL] [Abstract][Full Text] [Related]
22. Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study.
Kovács R; Csenki Z; Bakos K; Urbányi B; Horváth Á; Garaj-Vrhovac V; Gajski G; Gerić M; Negreira N; López de Alda M; Barceló D; Heath E; Kosjek T; Žegura B; Novak M; Zajc I; Baebler Š; Rotter A; Ramšak Ž; Filipič M
Water Res; 2015 Jun; 77():201-212. PubMed ID: 25889180
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and genotoxicity of cadmium oxide nanoparticles evaluated using in vitro assays.
Demir E; Qin T; Li Y; Zhang Y; Guo X; Ingle T; Yan J; Orza AI; Biris AS; Ghorai S; Zhou T; Chen T
Mutat Res Genet Toxicol Environ Mutagen; 2020; 850-851():503149. PubMed ID: 32247558
[TBL] [Abstract][Full Text] [Related]
24. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
Yuksel A; Bildik G; Senbabaoglu F; Akin N; Arvas M; Unal F; Kilic Y; Karanfil I; Eryılmaz B; Yilmaz P; Ozkanbaş C; Taskiran C; Aksoy S; Guzel Y; Balaban B; Ince U; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2926-35. PubMed ID: 26466914
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the genotoxicity of the tyrosine kinase inhibitor imatinib mesylate in cultured fish and human cells.
Novak M; Žegura B; Nunić J; Gajski G; Gerić M; Garaj-Vrhovac V; Filipič M
Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():14-21. PubMed ID: 28137363
[TBL] [Abstract][Full Text] [Related]
26. Chemical and toxicological characterisation of anticancer drugs in hospital and municipal wastewaters from Slovenia and Spain.
Isidori M; Lavorgna M; Russo C; Kundi M; Žegura B; Novak M; Filipič M; Mišík M; Knasmueller S; de Alda ML; Barceló D; Žonja B; Česen M; Ščančar J; Kosjek T; Heath E
Environ Pollut; 2016 Dec; 219():275-287. PubMed ID: 27814544
[TBL] [Abstract][Full Text] [Related]
27. Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.
Fischel JL; Formento P; Ciccolini J; Etienne-Grimaldi MC; Milano G
Anticancer Drugs; 2004 Nov; 15(10):969-74. PubMed ID: 15514566
[TBL] [Abstract][Full Text] [Related]
28. Validation of high-throughput genotoxicity assay screening using γH2AX in-cell western assay on HepG2 cells.
Khoury L; Zalko D; Audebert M
Environ Mol Mutagen; 2013 Dec; 54(9):737-46. PubMed ID: 24105934
[TBL] [Abstract][Full Text] [Related]
29. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
[TBL] [Abstract][Full Text] [Related]
30. 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells.
Halloran CM; Ghaneh P; Shore S; Greenhalf W; Zumstein L; Wilson D; Neoptolemos JP; Costello E
J Gene Med; 2004 May; 6(5):514-25. PubMed ID: 15133762
[TBL] [Abstract][Full Text] [Related]
31. Levels and risks of surface contamination by thirteen antineoplastic drugs in the Czech and Slovak hospitals and pharmacies.
Doležalová L; Bláhová L; Kuta J; Hojdarová T; Kozáková Š; Bláha L
Environ Sci Pollut Res Int; 2022 Apr; 29(18):26810-26819. PubMed ID: 34855176
[TBL] [Abstract][Full Text] [Related]
32. Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals.
Zounková R; Odráska P; Dolezalová L; Hilscherová K; Marsálek B; Bláha L
Environ Toxicol Chem; 2007 Oct; 26(10):2208-14. PubMed ID: 17867890
[TBL] [Abstract][Full Text] [Related]
33. New derivative of trans-dehydrocrotonin isolated from Croton cajucara shows reduced cytotoxic and genotoxic effects in hepatocellular carcinoma (HepG2) cell line.
Silva de Carvalho V; Melo Lima KM; Calandrini de Azevedo LF; Panarra Ferreira Gomes das Neves PA; Borges RDS; Nagamachi CY; Pieczarka JC
Toxicon; 2022 Dec; 220():106940. PubMed ID: 36223810
[TBL] [Abstract][Full Text] [Related]
34. Genotoxic effects induced by beta-myrcene following metabolism by liver HepG2/C3A human cells.
Orlando JB; Silva BO; Pires-Cunha CL; Hiruma-Lima CA; Gaivão IOM; Maistro EL
J Toxicol Environ Health A; 2019; 82(3):176-185. PubMed ID: 30806179
[TBL] [Abstract][Full Text] [Related]
35. Environmental relevant levels of the cytotoxic drug cyclophosphamide produce harmful effects in the polychaete Nereis diversicolor.
Fonseca TG; Auguste M; Ribeiro F; Cardoso C; Mestre NC; Abessa DMS; Bebianno MJ
Sci Total Environ; 2018 Sep; 636():798-809. PubMed ID: 29727846
[TBL] [Abstract][Full Text] [Related]
36. Flavonoid fraction of Cajanus cajan prohibited the mutagenic properties of cyclophosphamide in mice in vivo.
Abo-Zeid MAM; Abdel-Samie NS; Farghaly AA; Hassan EM
Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():1-5. PubMed ID: 29412864
[TBL] [Abstract][Full Text] [Related]
37. Influence of selected anti-cancer drugs on the induction of DNA double-strand breaks and changes in gene expression in human hepatoma HepG2 cells.
Novak M; Žegura B; Baebler Š; Štern A; Rotter A; Stare K; Filipič M
Environ Sci Pollut Res Int; 2016 Aug; 23(15):14751-61. PubMed ID: 26392091
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of thymoquinone against cyclophosphamide-induced genotoxic damage in human lymphocytes.
Yuksel S; Tasdemir S; Korkmaz S
Bratisl Lek Listy; 2017; 118(4):208-211. PubMed ID: 28471230
[TBL] [Abstract][Full Text] [Related]
39. Chemical characterisation and toxicity assessment in vitro and in vivo of the hydroethanolic extract of Terminalia argentea Mart. leaves.
Beserra AMSES; Vilegas W; Tangerina MMP; Ascêncio SD; Soares IM; Pavan E; Damazo AS; Ribeiro RV; Martins DTO
J Ethnopharmacol; 2018 Dec; 227():56-68. PubMed ID: 30142424
[TBL] [Abstract][Full Text] [Related]
40. Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs.
Villarini M; Dominici L; Piccinini R; Fatigoni C; Ambrogi M; Curti G; Morucci P; Muzi G; Monarca S; Moretti M
Mutagenesis; 2011 May; 26(3):359-69. PubMed ID: 21112930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
